Binance Labs, the enterprise capital arm of Binance, has introduced its funding in BIO Protocol, a platform designed to assist early-stage scientific analysis startups entry decentralized funding alternatives.
The funding sees Binance, powered by the native token BNB (BNB), make its first foray into decentralized science, the platform stated in an announcement on Nov. 8.
In line with Binance Labs, BIO Protocol is the equal of the “Y Combinator of on-chain science”, a reference to the U.S.-based VC agency and startup accelerator.
BIO Protocol advances the DeSci sector by offering a platform for scientists and traders to entry collective funding and co-ownership alternatives.
The platform presently operates by a community of seven biotech decentralized autonomous organizations, (also called BioDAOs) protecting areas akin to girls’s well being, psychological well being, and cryopreservation.
“BIO Protocol represents a major step ahead in DeSci by merging biotechnology and DeFi,” Andy Chang, funding director at Binance Labs, stated. “At Binance Labs, we’re devoted to unlocking groundbreaking developments that drive long-term, real-world affect by supporting initiatives constructing significant expertise – an method that intently aligns with our funding in BIO”.
The BIO Protocol staff plans to make use of the funding to broaden its BioDAOs additional, with seed funding out there for brand spanking new entities. BIO may also supply group and tokenomics assist because it seeks to broaden its presence and affect in scientific funding.
Binance Labs has lately elevated its footprint within the VC ecosystem, backing a number of initiatives in numerous business fields. This contains the funding platform’s backing of Lombard, a Bitcoin (BTC) liquid staking platform.
The crypto and blockchain-focused enterprise capital supplier has additionally invested in Solana (SOL) staking protocol Solayer and Telegram mini-app Blum.
